Steven J. Mento - Mar 10, 2023 Form 4 Insider Report for Histogen Inc. (HSTO)

Role
President and CEO, Director
Signature
/s/ Susan A. Knudson as attorney-in-fact for Steven J. Mento, Ph.D.
Stock symbol
HSTO
Transactions as of
Mar 10, 2023
Transactions value $
$0
Form type
4
Date filed
3/14/2023, 04:32 PM
Previous filing
Nov 9, 2022
Next filing
Jan 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HSTO Stock Option (right to buy) Award $0 +158K $0.00 158K Mar 10, 2023 Common Stock 158K $0.95 Direct F1
transaction HSTO Stock Option (right to buy) Award $0 +55.5K $0.00 55.5K Mar 10, 2023 Common Stock 55.5K $0.95 Direct F1, F2
transaction HSTO Stock Option (right to buy) Disposed to Issuer $0 -18.9K -100% $0.00* 0 Mar 10, 2023 Common Stock 18.9K $14.60 Direct F3, F4, F5
transaction HSTO Stock Option (right to buy) Disposed to Issuer $0 -7.58K -100% $0.00* 0 Mar 10, 2023 Common Stock 7.58K $5.40 Direct F3, F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the shares subject to the option vest one year after the date of grant, on 3/10/2024, and the remaining 1/36 of the shares vest on a monthly basis thereafter.
F2 The shares subject to this option are subject to forfeiture in the event that the shares available pursuant to the Issuer's 2020 Incentive Award Plan are not increased prior to the one-year anniversary and vesting of the award by an amount required to be available for issuance for all outstanding stock awards containing this forfeiture condition.
F3 Effective June 2, 2022, the Issuer effected a 1-for-20 reverse stock split of the Company's issued and outstanding common stock, par value $0.0001 per share.
F4 On March 10, 2023, the Issuer and the Reporting Person agreed to cancel the stock option award.
F5 1/4 of the shares subject to the option vested one year after the date of grant, on 11/8/2022, and the remaining 1/36 of the shares vest on a monthly basis thereafter.
F6 1/4 of the shares subject to the option vested one year after the date of grant, on 2/24/2023, and the remaining 1/36 of the shares vest on a monthly basis thereafter.